Bladder Cancer Antibodies

Bladder Antibodies

Bladder cancers are the fifth highest diagnosed cancer in the United States, with about 4.5% of new cancer cases classified as bladder cancer, contributing approx. 2.7% of cancer deaths yearly. As of 2012, there were approximately 580,000 people living with bladder cancer in the United States. Those diagnosed with bladder cancer have a 5 year survival rate of 77.4%. Over the last 10 years, rates for new bladder cancer cases have been falling on average 0.6% each year. Biocare Medical is proud to offer key bladder cancer antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Bladder Cancer, National Cancer Institute. Bethesda, MD,


Biocare Clone

Uroplakin II


Biocare Clone

URO-3 Triple Stain™






Ki-67 (R)





Biocare Clone